Cold Chain News: Q1 Highlights

Miss Chanice Henry
Posted: 04/20/2016

 The first quarter of 2016 hosted plenty of activity from the pharma and cold chain industries. This was seen in the form of patent challenges, landmark agreements, extreme market reactions as well as a nationwide medicine ban for hundreds of products. Read on for this quarter’s highlights from Cold Chain IQ & Pharma IQ.Biotech firm

To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Miss Chanice Henry
Posted: 04/20/2016

Join for Free


Amsterdam, The Netherlands
May 21 - 23, 2019
The Ritz-Carlton Coconut Grove, Miami, FL, United States
May 20 - 22, 2018

You Might Also Like

Your Quarterly Dose of Cold Chain & Pharma News – Q3
Within 2015’s third quarter, the pharma and biotech industries saw high levels of landmark... Read more
Contributor: Miss Chanice Henry